Louisville Medicine Volume 63, Issue 12 | Page 36

SPEAK YOUR MIND If you would like to respond to an article in this issue, please submit an article or letter to the editor. Contributions may be sent to [email protected] or may be submitted online at www.glms.org. The GLMS Editorial Board reserves the right to choose what will be published. Please note that the views expressed in Doctors’ Lounge or any other article in this publication are not those of the Greater Louisville Medical Society or Louisville Medicine. DEEP THOUGHTS Mary G. Barry, MD Louisville Medicine Editor [email protected] I was reading about a conference held in Britain recently, called “RE-WORK’s Deep Learning in Healthcare Summit 2016.” Brendan Frey, CEO of Deep Genomics, quoted Eric Lander from 2004: arterial flow in those with peripheral vascular disease, in the critical care setting, and in research labs. We also use them in the world of spies and interrogation and forensics. The lie detector machine has come a long way. “Genome. Bought the book. Hard to read.” Those who do psychological research and those who market new consumer goods can use entire integrated photoplethysmography (PPG) systems to measure physiologic arousal, fear, excitement - or boredom. iMotions, a company with origins in Copenhagen, describes itself as a “high tech software development company specialised in eye tracking and biometric solutions.” Their software is currently used in at least 12 different big city shopping centers where consumer focus groups meet. It integrates PPG, galvanic skin response, EEG, EMG, ECG, and facial expression analysis of participants’ reactions to the survey question, or video, or food, or a myriad of other products. This is fast, so that the client can get real-time feedback on the success or failure of its efforts “in a matter of hours not weeks,” the website proclaims. They say their “human behavior research tools” are used by Harvard, Yale and Stanford, among many others, in academic research. They say they are state of the art, entirely “plug n play,” and – my favorite – there are “No more Frankenstein solutions” in trying to integrate several different kinds of software. Theirs is “all in a box.” His company’s efforts revolve around trying to use Artificial Intelligence (AI) to speed up our human ability to understand, and therefore use, knowledge of our genome for the design of therapies for many and varied diseases. If we better understand the genome, we can create “fewer but better” molecules for anti-cancer and immune system drugs. Just as Google taught its invention to beat a pro player of the game GO for the first time, Mr. Frey believes we can yet maximize our translation of gene data into solutions for human illnesses. Others at the conference espoused using AI to teach biofeedback. Davide Morelli, the Chief Tech Officer of Biobeats, demonstrated an app called “Hear and Now.” It uses heart rate variance in an attempt to measure diaphragmatic excursion, to ensure that the stressed person actually Took Deep Breaths (the mantra of yogis and anesthesiologists everywhere) in the effort to relieve anxiety. The robot person in the app talks you through it. Already in hospitals, we use photoplethysmography devices – little bitty finger cuffs – to measure pulse volume and blood flow, as in measuring the pressure and viability of 34 LOUISVILLE MEDICINE Any viewer of the series Homeland can also think of numerous national security scenarios in which such information might be useful. Mental health specialists have used this technology in their research. The psychiatric treatment tool for PTSD and depression called EMDR (Eye Movement Desensitization and Reprocessing), as invented, simply uses rapid finger movements from the therapist in front of the patient’s gaze. The therapist asks the patient to recall an episode that caused emotional trauma, and interacts with the patient while continuing the rapid movement. (The idea is that rapid glancing side to side both reveals and informs the thought content and process, and the therapist can gradually teach the person to replace the disturbing thoughts with more positive ones by using these eye movements.) How it works is a topic of debate in psychological circles. I would think this iMotions sort of technological measurement could improve that therapy, which has been recommended by the Dept. of Defense to help veterans with combat-related PTSD. Depending on your worldview, you might be horrified that others could monitor your emotions that closely, or glad to be of service in selecting the Next Great Cereal. What is glaringly obvious from reading about this sort of super duper cool stuff is the absolute abyss separating the computing capabilities of programs designed to exploit certain elite markets and the public not-forprofit sector. Federal data banks have weaker firewalls; recall the hack that succeeded in accessing the identifying data of millions of current and former military personnel. The Plug n Play superiority touted in the